Clinical trial
Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917
NCT00290940 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00290940 |
|---|---|
| Title | Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917 |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of CS-917 as Monotherapy for Type 2 Diabetes |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | CS-917, metformin hydrochloride, pioglitazone |
| Enrollment | 400 |
| Start date | Jan 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Feb 13, 2006 |
| Last update posted | Sep 11, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: